Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2020-03-22 AGM Information
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
关于召开2020年第三次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice for convening the 2020 third extraordinary general meeting of shareholders of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the meeting date, voting methods, agenda items, and procedural instructions for shareholders. It does not contain financial statements or results but is an announcement related to a shareholders' meeting. The document is relatively short (2885 characters) and serves as a meeting notice rather than a report or voting results announcement. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2020-03-22 Chinese
国金证券股份有限公司关于无锡祥生医疗科技股份有限公司增加募投项目实施主体并使用募集资金向全资子公司增资以实施募投项目的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Guojin Securities regarding Wuxi Xiangsheng Medical Technology Co., Ltd.'s increase in the implementation subject of a fundraising project and the use of raised funds to increase capital in its wholly-owned subsidiary. It references regulatory approvals, fundraising details, board and supervisory meetings, and compliance with securities regulations. The document is a formal verification or audit opinion related to the use of raised funds and compliance with regulatory requirements, not a full annual or interim financial report, nor a simple announcement. It contains detailed financial and procedural information related to the fundraising and capital use, consistent with an audit or verification report. The document length is 3535 characters, which is relatively short but contains substantive content and opinions rather than just an announcement or certification. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2019
2020-03-22 Chinese
关于变更公司经营范围、修订公司章程并办理工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Wuxi Xiangsheng Medical Technology Co., Ltd. regarding changes to the company's business scope and amendments to the company charter, including the filing for industrial and commercial registration changes. It details the new business activities to be added, the specific amendments to the company charter, and the need for shareholder approval. There are no financial statements, audit information, or detailed financial data presented. The document is relatively short (2704 characters) and serves as a formal notification of corporate governance changes and business scope updates rather than a full report or financial filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-03-22 Chinese
第一届监事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a resolution passed at the 10th meeting of the first Supervisory Board of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the approval of a proposal to increase the implementation subject of a fundraising project and use part of the raised funds to increase capital in a wholly-owned subsidiary. The document includes voting results and references compliance with relevant laws and regulations. It does not contain financial statements or detailed financial data, nor is it a report or presentation. It is an official announcement of a board/management decision related to company governance and fundraising project implementation. Therefore, it fits best under 'Board/Management Information (MANG)' as it announces a board resolution and related management decision.
2020-03-22 Chinese
关于增加募投项目实施主体并使用部分募集资金向全资子公司增资以实施募投项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Wuxi Xiangsheng Medical Technology Co., Ltd. regarding the increase of the implementation subject of a fundraising project and the use of part of the raised funds to increase capital in a wholly-owned subsidiary. It details the approval by the board and supervisory board, the use of proceeds from an IPO, and compliance with regulatory requirements. The document is focused on the use of raised capital and changes in the capital deployment related to fundraising projects. It is not a full financial report, audit report, or earnings release. It is a specific update on capital usage and financing activities related to fundraising. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 3517 characters, which is relatively short but contains substantive information about capital use, not just an announcement of a report publication or a regulatory filing. Hence, the classification is CAP with high confidence.
2020-03-22 Chinese
独立董事关于第一届董事会第十七次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding a board meeting resolution about the use of raised funds and capital increase to a subsidiary. It references compliance with regulatory guidelines on the management and use of raised funds. The content is focused on board-level approval and independent director opinions rather than financial results, audit, or general regulatory announcements. It is not a full report, earnings release, or audit report. It is also not a simple announcement of voting results or a proxy solicitation. The document is best classified as Board/Management Information (MANG) because it relates to board meeting decisions and independent director opinions on corporate governance matters involving capital use and project implementation.
2020-03-22 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.